The table below shows LEMAITRE VASCULAR INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
$54.82M
$55.85M
Cost of revenue
$18.16M
$15.09M
$19.26M
$18.45M
$17.64M
$17.38M
Gross profit
$48.40M
$45.95M
$44.97M
$41.42M
$37.18M
$38.47M
R&D
$4.06M
$2.97M
$3.54M
$4.09M
$3.66M
$4.28M
LMAT annual revenue (10-K history)
LEMAITRE VASCULAR INC reported annual revenue of $249.60M for fiscal year 2025. That is up 13.5% from $219.86M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $89.15M (FY 2016) to $249.60M. Figures come from the company's audited annual reports as filed with the SEC.